Gene · 9436
Papers3,322
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,322
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Human CD3 complex is required for the generation of T-cell receptor-like chimeric antigen receptor targeting WT1 in natural killer cells. | Cancer Immunol Immunother | 2026 | 41843174 | PubTator, text mining | PubMed |
| The mouse gastric surface epithelial cell and its response to early Helicobacter pylori infection. | Virulence | 2026 | 41824631 | PubTator, text mining | PubMed |
| Advances in intratumoral immunotherapy from a neuro-immune-endocrine perspective for breast cancer treatment. | Front Oncol | 2026 | 41800053 | PubTator, text mining | PubMed |
| Integrative Roles of NK Receptors and γδ TCRs in γδ T Cell-Mediated Cancer Immunity. | Immune Netw | 2026 | 41800030 | PubTator, text mining | PubMed |
| Mechanisms of tumor cell evasion from NK cell-mediated killing and advances in NK cell-based cancer immunotherapy. | Pharm Sci Adv | 2026 | 41799416 | PubTator, text mining | PubMed |
| Enhancing cancer killing and natural killer cell persistence by targeting NOXA, a predictor of poor patient survival. | Mol Ther Oncol | 2026 | 41783357 | PubTator, text mining | PubMed |
| Dasatinib boosts γδ T cell expansion and memory phenotypes with enhanced antitumor immunity. | Cancer Immunol Immunother | 2026 | 41770421 | PubTator, text mining | PubMed |
| A novel GMP-manufactured medicinal product candidate composed of NK and γδ T cells as adjunct immunotherapy for hematopoietic stem cell transplantation. | Cell Transplant | 2026 | 41761987 | PubTator, text mining | PubMed |
| NKG2D CAR-T cells for solid tumor immunotherapy: advances, challenges, and future directions. | Front Immunol | 2026 | 41756289 | PubTator, text mining | PubMed |
| Enhancing Cancer Therapy with Hyperthermia: Synergistic Effects with Natural Compounds and Conventional Treatments. | Int J Mol Sci | 2026 | 41751791 | PubTator, text mining | PubMed |
| Engineering Bi-Specific CAR-NK Cells to Restore Antibody-Dependent Cellular Cytotoxicity in Solid Tumors. | Cells | 2026 | 41744817 | PubTator, text mining | PubMed |
| Feeder-free ex vivo expansion of cord blood-derived natural killer cells for enhanced proliferation and functional maturation. | Sci Rep | 2026 | 41735442 | PubTator, text mining | PubMed |
| Osteoclasts affect the anti-cancer activity of NK cells. | Front Immunol | 2026 | 41694400 | PubTator, text mining | PubMed |
| The gamma delta T/NK cell product GADEKILL as a novel immunotherapeutic tool for neuroblastoma patients: role of B7H6 and BTN2A1 in tumor cell killing. | Front Immunol | 2026 | 41694338 | PubTator, text mining | PubMed |
| Correction. | Oncoimmunology | 2026 | 41685700 | PubTator, text mining | PubMed |
| Discovery and preclinical evaluation of monoclonal antibodies and bispecific engagers targeting the NKG2A inhibitory receptor. | Sci Adv | 2026 | 41637511 | PubTator, text mining | PubMed |
| Gene Regulatory Programs of NK Cells Show That NCAM1 (CD56) and KIRs Are Controlled by Genetically Polymorphic Distal Regulatory Elements. | Eur J Immunol | 2026 | 41636199 | PubTator, text mining | PubMed |
| [cGAS-STING agonist cGAMP enhances natural killer cell-mediated cytotoxicity against gastric cancer cells]. | Nan Fang Yi Ke Da Xue Xue Bao | 2026 | 41633700 | PubTator, text mining | PubMed |
| TGF-β in tumor development and progression: mechanisms and therapeutics. | Mol Biomed | 2026 | 41615651 | PubTator, text mining | PubMed |
| SCFAs' pleiotropic role in pathogenesis and salutogenesis: mechanisms in exacerbation and regulation of inflammation and fibrosis from gut to host. | J Med Microbiol | 2026 | 41609721 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9436/papers?page=2